Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death

Nanomedicine

Volumn 3, Issue 4, 2008, Pages 507-519

  Cho, Youngnam ^a   Shi, Riyi ^a,b   Borgens, Richard B ^a,b   Ivanisevic, Albena ^b,c  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Acrolein; Controlled release; Drug delivery; Hydralazine; Mesoporous silica nanoparticles; PC12 cells; Polyethylene glycol

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACROLEIN; ADENOSINE TRIPHOSPHATE; GLUTATHIONE; HYDRALAZINE; LACTATE DEHYDROGENASE; MACROGOL; NANOPARTICLE; SILICON DIOXIDE;

ADSORPTION; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; CYTOPLASM; DESORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; MITOCHONDRION; NANOENCAPSULATION; NERVE CELL LESION; NERVE CELL MEMBRANE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION;

ACROLEIN; ANIMALS; CELL MEMBRANE; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; HYDRALAZINE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NANOTECHNOLOGY; PC12 CELLS; POLYETHYLENE GLYCOLS; POROSITY; RATS; SILICON DIOXIDE;

EID: 56549114614     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/17435889.3.4.507     Document Type: Article

References (38)

1. Burcham P, Fontaine F, Kaminskas L, Petersen D, Pyke S: Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity. Mol. Pharmacol. 65, 655-664 (2004).
2. Burcham P, Pyke S: Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection. Mol. Pharmacol. 69, 1056-1065 (2006).
3. Liu-Snyder P, McNally H, Shi R, Borgens R: Acrolein-mediated mechanisms of neuronal death. J Neurosci. Res. 84, 209-218 (2006).
4. Kaminskas L, Pyke S, Burcham P: Reactivity of hydralazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde. Org. Biomol. Chem. 2, 2578-2584 (2004).
5. Furuhata A, Nakamura M, Osawa T, Uchida K: Thiolation of protein-bound carcinogenic aldehyde. J. Biol. Chem. 277, 27919-27926 (2002).
6. Luo J, Shi R: Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem. Int. 44, 475-486 (2004).
7. Luo J, Sid R: Acrolein induces oxidative stress in brain mitochondria. Neurochem. Int. 46, 243-252 (2005).
8. Luo J, Robinson J, Borgens R: Acrolein-induced cell death in PC12 cells: role of mitochrondria-medicated oxidative stress. Neurochem. Int. 47, 449-457 (2005).
9. Shi R, Luo J, Peasley M: Acrolein inflicts axonal membrane disruption and conduction loss in isolated guinea pig spinal cord. Neuroscience 115, 337-340 (2002).
10. Liu-Snyder P, Borgens R, Shi R: Hydralazine rescues PC12 cells from acrolein-mediated death. J. Neurosci. Res. 84, 219-227 (2006).
11. Luo J, Borgens R, Shi R: Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J. Neurochemistry 83, 471-480 (2002).
12. Luo J, Borgens R, Shi R: Polyethylene glycol improves function and reduces oxidative stress in synaptosomes following spinal cord injury. J. Neurotrauma 21, 994-1007 (2004).
13. Borgens R: Cellular Engineering: Molecular repair of membranes to rescue cells of the damaged nervous system. Neurosurgery 49, 370-379 (2001).
14. Borgens R, Shi R: Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol. FASEB J 14, 27-35 (2000).
15. Luo J, Shi R: Diffusive oxidative stress following acute spinal cord injury and the inhibition by polyethylene glycol. Neurosci. Lett. 359, 167-170 (2004).
16. Koch A, Borgens R: polyetylene glycol treatment after traumatic brain injury reduces amyloid precursor protein accumulation in degenerating axons. J. Neuroci. Res. 83, 1558-1563 (2006).
17. Koob A, Duerstock B, Babbs C, Sun Y, Borgens R: Intravenous polyethylene glycol inhibits the loss of cerebral cells after brain injury. J. Neurotrauma 22, 1092-1111 (2005).
18. Balas F, Manzano M, Horcajada P, Vallet-Regi M: Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J. Am. Chem. Soc. 128, 8116-8117 (2006).
19. Lai C, Trewyn BG, Jeftinija DM et al.: A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotrasmitters and drug molecules. J. Am. Chem. Soc. 125, 4451-4459 (2003).
20. Munoz B, Ramila A, Perez-Pariente, J. Diaz I, Vallet-Regi M: MCM-41 organic modification as drug delivery rate regulator. Chem. Mater. 15, 500-503 (2003).
21. Trewyn B, Slowing I, Giri W, Chen H, Lin V: Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc. Chem. Res. 40, 846-853 (2007).
22. Wang L, Wang K, Santra S et al.: Watching silica nanoparticles glow in the biological world. Anal. Chem. 78(3), 646-654 (2006).
23. Andersson J, Rosenholm J, Areva S, Linden M: Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro-and mesoporous silica matrices. Chem. Mater. 16, 4160-4167 (2004).
24. Arruebo M, Galin M, Navascues N et al.: Development of magnetic nanostructured silica-based materials as potential vectors for drug-delivery applications. Chem. Mater. 18, 1911-1919 (2006).
25. Chung T, Wu SH, Yao M et al.: The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesnchymal stem cells. Biomaterials 28, 2959-2966 (2007).
26. Kim J, Lee JE, Lee J et al.: Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J. Am. Chem. Soc. 128, 688-689 (2006).
27. Lin Y-S, Hung Y, Su J-K et al.: Gadolinium(III)-incorporated nanosized mesoporous silica as potential magnetic resonance imaging contrast agents. J. Phys. Chem. B 108, 15608-15611 (2004).
28. Lin Y-S, Tsai C-P, Huang H-Y et al.: Well-ordered & mesoporous & silica nanoparticles as cell markers. Chem. Mater. 17, 4570-4573 (2005).
29. Slowing I, Trewyn B, Lin V. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J. Am. Chem. Soc. 129, 8845-8849 (2007).
30. Yang H, Kao W: Dendrimers for pharmaceutical and biomedical applications. J. Biomater. Sci. Polym. Ed. 17, 3-19 (2006).
31. Liu-Snyder P, Logan M, Shi R, Smith D, Borgens R: Neuroprotection from secondary injury by polyethylene glycol requires its internalization. J. Exp. Biol. 210, 1-8 (2007).
32. Lee J, Lentz B: Evolution of lipid structures during model membrane fusion and the relation of this process to cell membrane fusion. Biochemistry 36, 6251-6259 (1997).
33. Lee R, Myerov A, Maloney C: Promising therapy for cell membrane damage. Ann. NY Acad. Sci. 720, 239-245 (1994).
34. Lee R, River L, Pan F, Ji L, Wollmann R: Surfactant-induced sealing of electropermeabilzed sckeletal muscle membranes in vivo. Proc. Natl Acad. Sci. USA 89, 4524-4528 (1992).
35. Borgens R, Shi R: Acute repair of crushed guinea pig spinal cord by polyethylene glycol. J. Neurophysiol. 81, 2406-2414 (1999).
36. Borgens R, Shi R, Bohnert D: Behavioral recovery from spinal cord injury following delayed application of polyethylene glycol. J. Exp. Biol. 205, 1-12 (2002).
37. Laverty P, Leskovar A, Breur GJ et al.: A preliminary study of intravenous surfactants in paraplegic dogs: polymer therapy in canine clinical SCI. J. Neurotrauma 21, 1767-1777 (2004).
38. Miyoshi N, Oubrahim H, Chock P, Stadtman E: Age-dependent cell death and the role of ATP in hydrogen peroxide-induced apoptosis and necrosis. Proc. Natl Acad. Sci. USA 87, 1727-1731 (2006).